{"mainPropery":{"diseaseId":7058,"diseaseName":"Localized scleroderma","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7058/localized-scleroderma","synonyms":["Scleroderma, localized","Localized fibrosing scleroderma"],"synonyms-with-source":[{"name":"Scleroderma, localized"},{"name":"Localized fibrosing scleroderma","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"90289"},{"identifierType":"UMLS","identifierId":"C0036420"}]},"diseaseCategories":[{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":194,"resourceName":"Scleroderma Foundation","abbreviation":"","address1":"300 Rosewood Drive, Suite 105","address2":"","address3":"","address4":"","address5":"","city":"Danvers","state":"MA","zip":"01923","country":"United States","phone":"+1-978-463-5843 ","tty":"","tollFree":"1-800-722-4673 (HOPE)","fax":"+1-978-463-5809","email":"sfinfo@scleroderma.org","url":"https://www.scleroderma.org","freeText":""},{"resourceID":359,"resourceName":"International Scleroderma Network (ISN)","abbreviation":"","address1":"7455 France Ave So #266","address2":"","address3":"","address4":"","address5":"","city":"Edina","state":"MN","zip":"55435-4702 ","country":"United States","phone":"+1-952-831-3091","tty":"","tollFree":"1-800-564-7099","fax":"","email":"isn@sclero.org","url":"https://www.sclero.org/index.html","freeText":""},{"resourceID":360,"resourceName":"Scleroderma Research Foundation","abbreviation":"","address1":"220 Montgomery Street, Suite 484","address2":"","address3":"","address4":"","address5":"","city":"San Francisco","state":"CA","zip":"94104 ","country":"United States","phone":"+1-415-834-9444 ","tty":"","tollFree":"","fax":"","email":"info@srfcure.org","url":"https://srfcure.org/","freeText":""},{"resourceID":3510,"resourceName":"Scleroderma Society of Ontario","abbreviation":"","address1":"41 King William Street, Suite 202","address2":"","address3":"","address4":"","address5":"","city":"Hamilton, ON","state":"","zip":"L8R 1A2","country":"Canada","phone":"+1-905-544-0343","tty":"","tollFree":"1-888-776-7776 (Helpline)","fax":"","email":"info@sclerodermaontario.ca","url":"https://www.sclerodermaontario.ca/","freeText":""},{"resourceID":3569,"resourceName":"Scleroderma & Raynaud's UK","abbreviation":"SRUK","address1":"18-20 Bride Lane ","address2":"","address3":"","address4":"","address5":"","city":"London","state":"","zip":"EC4Y 8EE","country":"United Kingdom","phone":"020 7000 1925 (Office)","tty":"","tollFree":"0800 311 2756 (Helpline)","fax":"","email":"info@sruk.co.uk","url":"https://www.sruk.co.uk","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=(Localized%5BTitle%5D+AND+scleroderma%5BTitle%5D)+AND+%22loattrfree+full+text%22%5Bsb%5D&WebEnv=0ZbZIoku7dMeVq6EtV61Pq7AbcHKG52zBezopbiMZDNU_lONDLosUMx5Ml74APP12JVAyrfuzcQcE%40D47C30596656F220_0034SID&WebEnvRq=1' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Localized scleroderma. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Localized+scleroderma%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Localized scleroderma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":803,"resourceId":1482,"resourceName":"Scleroderma Clinical Trials Consortium","descriptionText":"The <a href=\"http://sites.bu.edu/sctc/\"><a href='https://sites.bu.edu/sctc/' target='_blank'>Scleroderma Clinical Trials Consortium</a></a> is an international organization of scleroderma clinical researchers. The consortium Web site&nbsp;contains&nbsp;a listing of active scleroderma trials,&nbsp;past copies of the Scleroderma Care and Research&nbsp;journal, and&nbsp;a tool for finding your nearest member institution.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":804,"resourceId":1482,"resourceName":"Scleroderma Clinical Trials Consortium","descriptionText":"Select volumes of the <a href='http://www.med.umich.edu/scleroderma/professionals/journal.htm' target='_blank'>Scleroderma Care and Research Journal</a><em> </em>can be viewed by visiting the Scleroderma Clinical Trials Consortium Web site. Click on the link above to learn more.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/scleroderma.html' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicine.com/derm/TOPIC272.HTM' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=90289' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1562,"resourceId":2179,"resourceName":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","descriptionText":"The <a href='http://www.niams.nih.gov/Health_Info/Scleroderma/default.asp#2' target='_blank'>National Institute of Arthritis and Musculoskeletal and Skin Diseases</a> (NIAMS) support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases, the training of basic and clinical scientists to carry out this research, and the dissemination of information on research progress in these diseases.  Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:8472' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Localized scleroderma. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Localized scleroderma:<br />\r\n<a href='https://conquerssc.org/' target='_blank'>CONQUER Registry?</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":772,"questionText":"What is localized scleroderma?","answerText":"<p><strong>Localized scleroderma</strong> is characterized by thickening of the skin from excessive collagen deposits. Collagen is a protein normally present in our skin that provides structural support. However, when too much collagen is made, the skin becomes stiff and hard.[495] Localized types of scleroderma are those limited to the skin and related tissues and, in some cases, the muscle below. Internal organs are not affected by localized scleroderma, and localized scleroderma can never progress to the systemic form of the disease. Often, localized conditions improve or go away on their own over time, but the skin changes and damage that occur when the disease is active can be permanent. For some people, localized scleroderma is serious and disabling.[496]</p>\r\n<p>There are two generally recognized types of localized scleroderma: morphea and linear.[496]<font face=Perpetua color=#231f20 size=3></p></font>\r\n<dl>\r\n<dd>\r\n<p><strong><em></em></strong>&nbsp;</p></dd></dl>","dateModified":"2012-04-03T17:07:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":9513,"relatedDiseaseName":"Linear scleroderma","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10485,"relatedDiseaseName":"Morphea","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10308,"relatedDiseaseName":"Scleroderma","relation":"Parent","isRare":false,"hasGardPage":true}],"gardCases":[{"caseId":21751,"abbreviatedInquiry":"I have been diagnosed with morphea. Can you please provide me with patient-friendly information about this disease?","caseQuestions":[{"questionId":772,"questionText":"What is localized scleroderma?","answerText":"<p><strong>Localized scleroderma</strong> is characterized by thickening of the skin from excessive collagen deposits. Collagen is a protein normally present in our skin that provides structural support. However, when too much collagen is made, the skin becomes stiff and hard.[495] Localized types of scleroderma are those limited to the skin and related tissues and, in some cases, the muscle below. Internal organs are not affected by localized scleroderma, and localized scleroderma can never progress to the systemic form of the disease. Often, localized conditions improve or go away on their own over time, but the skin changes and damage that occur when the disease is active can be permanent. For some people, localized scleroderma is serious and disabling.[496]</p>\r\n<p>There are two generally recognized types of localized scleroderma: morphea and linear.[496]<font face=Perpetua color=#231f20 size=3></p></font>\r\n<dl>\r\n<dd>\r\n<p><strong><em></em></strong>&nbsp;</p></dd></dl>","dateModified":"2012-04-03T17:07:00","references":[{"referenceId":495,"authors":"","articleTitle":"Localized Scleroderma","bookWebsiteJournalTitle":"Scleroderma Foundation","date":"","url":"http://www.scleroderma.org/site/DocServer/Localized.pdf?docID=317","dateAccessed":"2011-06-23T00:00:00"},{"referenceId":496,"authors":" ","articleTitle":"Scleroderma","bookWebsiteJournalTitle":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","date":"May 2010","url":"http://www.niams.nih.gov/Health_Info/Scleroderma/","dateAccessed":"2011-06-23T00:00:00"}]},{"questionId":767,"questionText":"What causes morphea?","answerText":"The underlying cause of morphea is poorly understood. Theories on the cause are often drawn from studies of <a href=\"https://rarediseases.info.nih.gov/diseases/9748/systemic-sclerosis\" target=\"_blank\">systemic sclerosis</a>. A variety of factors, including <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000816.htm\" target=\"_blank\">autoimmunity</a>, genetics, and vascular dysfunction may play a role in morphea. Multiple environmental factors (such as radiation, infections, skin trauma, or environmental exposures) also have been proposed as contributors to the development of morphea.[12360]","dateModified":"2018-02-15T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":12360,"authors":"Heidi Jacobe","articleTitle":"Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults","bookWebsiteJournalTitle":"UpToDate","date":"September, 2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":768,"questionText":"What are the signs and symptoms of morphea?","answerText":"The signs and symptoms of morphea can vary depending on the type and severity. Morphea usually causes reddish patches of skin that thicken (sclerosis) into firm, oval-shaped areas. The center of each patch may develop a lighter center.[12343] These patches sweat less than unaffected areas and may lose hair over time. Patches most often occur on the chest, stomach, and back, and sometimes occur on the face, arms, and legs.[12342][12343]&nbsp;<span style=\"font-size: 12pt;\">According to the localization and deepness of the lesions morphea may be classified in:[12342][12343][12360]</span>\r\n<ul>\r\n    <li>Localized or circumscribed which is limited to one or several patches on the trunk, legs and arms&nbsp;</li>\r\n    <li>Generalized, spread over larger areas of the body, in the trunk, legs and limbs&nbsp;</li>\r\n    <li>Linear,&nbsp;&nbsp;where there are linear bands of thick skin that involve the deeper layers of the skin and are localized in the legs, arms, upper body or head</li>\r\n    <li>Morphea profunda or pansclerotic, which involves also the tissue below the skin and may restrict the joint movement.</li>\r\n</ul>","dateModified":"2018-02-15T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":12342,"authors":"","articleTitle":"Handout on Health: Scleroderma","bookWebsiteJournalTitle":"NIAMS","date":"February, 2015","volume":"","pages":"","url":"http://www.niams.nih.gov/Health_Info/Scleroderma/default.asp#2","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12343,"authors":"","articleTitle":"Morphea","bookWebsiteJournalTitle":"Mayo Clinic","date":"September 29, 2015","volume":"","pages":"","url":"http://www.mayoclinic.org/diseases-conditions/morphea/basics/definition/con-20028397","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12360,"authors":"Heidi Jacobe","articleTitle":"Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults","bookWebsiteJournalTitle":"UpToDate","date":"September, 2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":769,"questionText":"How might morphea be treated?","answerText":"Treatment for morphea is aimed at&nbsp;controlling the symptoms and depends on the severity  and body surface area involved. In general, active disease (present &lt;3 months or with symptoms of inflammation) is most responsive to treatment.&nbsp;Because morphea typically goes away on its own eventually, treating the condition is optional for  uncomplicated, localized cases.<br />\r\n<br />\r\nThe majority of adults with morphea are managed with observation, topical medications, or <a href=\"http://www.dermnetnz.org/topics/phototherapy/\" target=\"_blank\">phototherapy</a>.&nbsp;Aggressive, <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=45922\" target=\"_blank\">systemic therapy</a>&nbsp;with <a href=\"https://medlineplus.gov/druginfo/meds/a682019.html\" target=\"_blank\">methotrexate</a>&nbsp;and/or <a href=\"https://medlineplus.gov/steroids.html\" target=\"_blank\">glucocorticoids</a>&nbsp;is needed for those with active, deep morphea; lesions that may cause significant cosmetic disfigurement; joint contractures; or other functional impairment. Occupational and physical therapy are also important for those at risks for physical limitations. Phototherapy is also preferred for those with generalized morphea, but it is not an option for those with deep morphea due to the poor ability of ultraviolet light to penetrate deep tissues.[9999]<br />\r\n<br />\r\n<a href=\"http://emedicine.medscape.com/article/1065782-treatment\" target=\"_blank\">Detailed information about how morphea might be treated can be viewed here on Medscape Reference's website</a>.","dateModified":"2018-02-15T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9999,"authors":"Heidi Jacobe","articleTitle":"Treatment of morphea (localized scleroderma) in adults","bookWebsiteJournalTitle":"UpToDate","date":"September, 2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":770,"questionText":"What is the long-term outlook for people with morphea?","answerText":"Morphea usually has a benign, self-limited course and life expectancy is typically normal. When lesions are superficial and circumscribed, the skin condition tends to slowly go away with time, with each individual lesion lasting an average of 3-5 years. However, some patients develop new lesions over their lifetimes.[12106] Even after morphea resolves,&nbsp;changes in skin color&nbsp;may last for years.[12363]<br />\r\n<br />\r\nLinear morphea usually lasts longer, but also eventually improves.[12363] Linear and deep (panslerotic) morphea may cause considerable morbidity, especially in children, interfering with growth. Joint contractures, limb-length discrepancy, and prominent facial atrophy (shrinkage of underlying tissues) can cause substantial disability and deformity in people with linear or deep morphea.[12106]&nbsp;Limbs affected by severe morphea may be stiff and weak if there is muscle wasting.[12363]","dateModified":"2018-02-15T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":12106,"authors":"Nguyen JV","articleTitle":"Morphea","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1065782","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12363,"authors":"Oakley A","articleTitle":"Morphea","bookWebsiteJournalTitle":"DermNet NZ","date":"1999","volume":"","pages":"","url":"http://www.dermnetnz.org/topics/morphoea/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":771,"questionText":"Who can I contact to learn more about morphea and other forms of localized scleroderma?","answerText":"You can learn more about morphea and other forms of localized scleroderma by visiting the following link from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of NIH.<br><a href=\"http://www.niams.nih.gov/hi/topics/scleroderma/scleroderma.htm#2\" target=_blank>http://www.niams.nih.gov/hi/topics/scleroderma/scleroderma.htm#2</a><br><br>Additionally, NIAMS offers printed materials on scleroderma. We recommend calling the toll-free number below to request a copy of this information.<br><br>National Institute of Arthritis and Musculoskeletal and Skin Diseases Information Clearinghouse<br>National Institutes of Health<br>1 AMS Circle<br>Bethesda, Maryland 20892-3675<br>Toll free: 877-22-NIAMS<br>Telephone: 301-495-4484<br>TTY: 301-565-2966<br>Fax: 301-718-6366<br>Email: <a href=\"mailto:niamsinfo@mail.nih.gov\">niamsinfo@mail.nih.gov</a><br>Web site: <a href=\"http://www.niams.nih.gov/hi/index.htm\" target=_blank>http://www.niams.nih.gov/hi/index.htm</a><br><br>More information on scleroderma can be found at the following link from MEDLINEplus, the National Library of Medicine Web site designed to help you research your health questions.<br><a href=\"http://www.nlm.nih.gov/medlineplus/scleroderma.html\" target=_blank>http://www.nlm.nih.gov/medlineplus/scleroderma.html</a><br>","dateModified":"2013-09-12T16:21:00","references":[]},{"questionId":773,"questionText":"How can I locate research for morphea?","answerText":"<p><a href=\"http://clinicaltrials.gov/ct2/results?term=morphea\" target=_blank>ClinicalTrials.gov</a> lists trials that are studying or have studied morphea. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. </p>\r\n<p>You can also contact the Patient Recruitment and Public Liaison (PRPL) Office at the National Institutes of Health (NIH). We recommend calling the toll-free number listed below to speak with a specialist, who can help you determine if you are eligible for any clinical trials.&nbsp;&nbsp; </font></p>\r\n<p>Patient Recruitment and Public Liaison Office<br>NIH Clinical Center<br>Bethesda, Maryland 20892-2655<br>Toll-free: 800-411-1222<br>Fax: 301-480-9793<br>Email: </font><a href=\"mailto:prpl@mail.cc.nih.gov\">prpl@mail.cc.nih.gov</a> <br>Web site:&nbsp; </font><font face=\"times new roman, times, serif\"><a href=\"http://clinicalcenter.nih.gov/\">http://clinicalcenter.nih.gov/</a></font><br><br>If you are interested in enrolling in a clinical trial, you can find helpful general information on clinical trials at the following ClinicalTrials.gov Web page.<br><a href=\"http://clinicaltrials.gov/ct2/info/understand\">http://clinicaltrials.gov/ct2/info/understand</a></p>\r\n<p>A tutorial about clinical trials that can also help answer your questions can be found at the following link from the National Library of Medicine:<br><a href=\"http://www.nlm.nih.gov/medlineplus/tutorials/cancerclinicaltrials/htm/lesson.htm\">http://www.nlm.nih.gov/medlineplus/tutorials/cancerclinicaltrials/htm/lesson.htm</a></p>\r\n<p>Resources on many charitable or special-fare flights to research and treatment sites and low-cost hospitality accommodations for outpatients and family members, as well as ambulance services, are listed on the Web site of the Office of Rare Diseases (ORD), part of the National Institutes of Health.<br><a href=\"http://rarediseases.info.nih.gov/Resources.aspx?PageID=8\">http://rarediseases.info.nih.gov/Resources.aspx?PageID=8</a></p>","dateModified":"2011-06-23T15:18:00","references":[]},{"questionId":774,"questionText":"How can I find journal articles on morphea?","answerText":"<a href=\"http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=DetailsSearch&amp;Term=morphea%5BTitle%5D+AND+(hasabstract%5Btext%5D+AND+%222003%2F06%2F06%22%5BPDat%5D+%3A+%222008%2F06%2F03%22%5BPDat%5D)\" target=_blank>PubMed</a> lists journal articles that discuss morphea. Click on the link to go to PubMed and review citations to these articles. ","dateModified":"2013-09-12T16:18:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":9340,"phenoTypeName":"Cigarette-paper scars","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10277,"phenoTypeName":"Hyperpigmentation of the skin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8290,"phenoTypeName":"Hypopigmentation of the skin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1180,"phenoTypeName":"Stiff skin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14505,"phenoTypeName":"Skeletal muscle atrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7919,"phenoTypeName":"Arthralgia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3106,"phenoTypeName":"Flexion contracture of toe","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1895,"phenoTypeName":"Hemiatrophy of lower limb","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1896,"phenoTypeName":"Hemiatrophy of upper limb","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6926,"phenoTypeName":"Lipoatrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10750,"phenoTypeName":"Scarring alopecia of scalp","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3066,"phenoTypeName":"Split hand","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[],"EncodedName":"Localized_scleroderma"}